Evidence map›Paper›PMID 41464734›Full record

ArticleJournal of clinical medicine2025

Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents.

Angelica Lindén Hirschberg, Lali Pkhaladze, Kristina Gemzell-Danielsson, Kai Haldre, Kateryna Ruban, Nina Flerin, Guillaume Chatel, Dan Apter

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angelica Lindén HirschbergDepartment of Women's and Children's Health, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0001-6481-6277
Lali PkhaladzeProf. Zhordania and Prof. Khomasuridze Institute of Reproductology, Tbilisi 0186, Georgia.ORCID 0000-0003-4690-9140
Kristina Gemzell-DanielssonDepartment of Women's and Children's Health, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0001-6516-1444
Kai HaldreEast Tallinn Central Hospital Women's Clinic, 10138 Tallinn, Estonia.
Kateryna RubanEstetra SRL, a Wholly Owned Subsidiary of Gedeon Richter Plc., 4000 Liège, Belgium.
Nina FlerinEstetra SRL, a Wholly Owned Subsidiary of Gedeon Richter Plc., 4000 Liège, Belgium.
Guillaume ChatelEstetra SRL, a Wholly Owned Subsidiary of Gedeon Richter Plc., 4000 Liège, Belgium.
Dan ApterDepartment of Obstetrics and Gynaecology, University of Helsinki, 00100 Helsinki, Finland.ORCID 0000-0002-5175-8845

Funding

Estetra SRL NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adolescentscycle controldysmenorrheaestetrol/drospirenonesafetytolerability

Identifiers

PMID41464734
PMCPMC12733561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.